In silico and in vitro Blood-Brain Barrier models for early stage drug discovery

被引:0
|
作者
Saber, Ralph [1 ]
Rihana, Sandy [1 ]
Mhanna, Rami [2 ]
机构
[1] Holy Spirit Univ Kasl USEK, Biomed Engn Dept, Jounieh, Lebanon
[2] Amer Univ Beirut AUB, Biomed Engn Program, Beirut, Lebanon
关键词
blood-brain barrier model; ADMET; 3D printing; paper-based cell culture; artificial intelligence; classification; machine learning; genetic algorithm; artificial neural network; PENETRATION;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Drug discovery is a long and costly procedure that requires the prediction of many candidate molecules' attributes, including ADMET (Absorption, Distribution, Metabolism, Elimination and Toxicity) characteristics. Pharmaceutical companies complementarily use in silico and in vitro models at different stages for this purpose. The permeability across the blood-brain barrier (BBB) is a very important ADMET property since it inhibits the delivery of multiple drugs to the brain. In this context, this paper presents two BBB models designed and implemented for early stage drug discovery: an in silico and an in vitro one. The highest overall accuracy obtained with the former model was 96.23% with both Quadratic Discriminant Analysis and Support Vector Machine classifiers, after applying Genetic Algorithm for feature selection. In the latter case, we have proposed the novel approach of applying cellulose filter papers of 2 mu m porosity with PLA 3D printed inserts in order to build a valid in vitro model. Different coatings were tested to increase the adhesion of the endothelial cells to the substrate. The highest degree of confluency was obtained with the collagen type I coating. Moreover, the highest trans-endothelial electric resistance (TEER) value obtained was 45.6 +/- 12.07 Omega.cm(2) which is comparable to the values reported using the same cell line. This shows that paper-based cell culture can be a promising tool for the implementation of low-cost BBB models that could validate and refine computational models.
引用
收藏
页码:28 / 31
页数:4
相关论文
共 50 条
  • [1] Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery
    Vandenhaute, Elodie
    Sevin, Emmanuel
    Hallier-Vanuxeem, Dorothee
    Dehouck, Marie-Pierre
    Cecchelli, Romeo
    DRUG DISCOVERY TODAY, 2012, 17 (7-8) : 285 - 290
  • [2] Drug delivery and in vitro models of the blood-brain barrier
    Cucullo, L
    Aumayr, B
    Rapp, E
    Janigro, D
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2005, 8 (01) : 89 - 99
  • [3] In Vitro Models of the Blood-Brain Barrier for the Study of Drug Delivery to the Brain
    Wilhelm, Imola
    Krizbai, Istvan A.
    MOLECULAR PHARMACEUTICS, 2014, 11 (07) : 1949 - 1963
  • [4] In vitro models of the blood-brain barrier to study drug delivery to the brain
    Couraud, Pierre-Olivier
    DRUG METABOLISM REVIEWS, 2009, 41 : 15 - 15
  • [5] In vitro models for the blood-brain barrier
    Garberg, P
    Ball, M
    Borg, N
    Cecchelli, R
    Fenart, L
    Hurst, RD
    Lindmark, T
    Mabondzo, A
    Nilsson, JE
    Raub, TJ
    Stanimirovic, D
    Terasaki, T
    Öberg, JO
    Österberg, T
    TOXICOLOGY IN VITRO, 2005, 19 (03) : 299 - 334
  • [6] In vitro models of the blood-brain barrier
    Garberg, P
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 1998, 26 (06): : 821 - 847
  • [7] In vitro models of the blood-brain barrier
    Wilhelm, Imola
    Fazakas, Csilla
    Krizbai, Istvan A.
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2011, 71 (01) : 113 - 128
  • [8] New experimental models of the blood-brain barrier for CNS drug discovery
    Kaisar, Mohammad A.
    Sajja, Ravi K.
    Prasad, Shikha
    Abhyankar, Vinay V.
    Liles, Taylor
    Cucullo, Luca
    EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (01) : 89 - 103
  • [9] Current in vitro and in silico models of blood-brain barrier penetration: A practical view
    Vastag, Monika
    Keseru, Gyoergy M.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2009, 12 (01) : 115 - 124
  • [10] Blood-brain barrier in vitro models as tools in drug discovery: Assessment of the transport ranking of antihistaminic drugs
    Neuhaus, W.
    Mandikova, J.
    Pawlowitsch, R.
    Linz, B.
    Bennani-Baiti, B.
    Lauer, R.
    Lachmann, B.
    Noe, C. R.
    PHARMAZIE, 2012, 67 (05): : 432 - 439